Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Slow Growth And Tough Market Make China An Intriguing Puzzle For Indian Companies

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - For large Indian drug companies, China has been a traditional and, to an extent, a dreaded rival in the business of pharmaceutical raw materials. Gargantuan Chinese factories that cropped up in the eighties almost killed scores of Indian bulk drug manufacturing units as every pricing strategy the Indian outfits could conceive of failed to beat the quotations offered by Chinese manufacturers to global brand name companies

You may also be interested in...

Down But Not Out, Ranbaxy Eyes Generics Blockbuster Launches In China

Fierce competition makes China a tough nut to crack for generics, something India’s largest drug manufacturer Ranbaxy says it has learned the hard way, but after walking away from a joint venture, the firm is ready to try again.

Dr. Reddy’s Eyes Big Splash In China Market With A Three-fold Sales Jump

After a prolonged wait, Dr. Reddy’s finally finds rhythm in the worlds’ fastest growing market and eyes growth in niche areas.

Daiichi Sankyo Buys Out China Shell Company To Breathe New Life Into Ranbaxy

While Daiichi Sankyo has relied on Ranbaxy's sales presence in other emerging markets, it has decided to buy a stake in China to give Ranbaxy's portfolio a second chance in the country.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts